JP2025512061A5 - - Google Patents

Info

Publication number
JP2025512061A5
JP2025512061A5 JP2024560444A JP2024560444A JP2025512061A5 JP 2025512061 A5 JP2025512061 A5 JP 2025512061A5 JP 2024560444 A JP2024560444 A JP 2024560444A JP 2024560444 A JP2024560444 A JP 2024560444A JP 2025512061 A5 JP2025512061 A5 JP 2025512061A5
Authority
JP
Japan
Prior art keywords
sequence
rna
nucleic acid
sequence encoding
expression cassette
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024560444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025512061A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/059361 external-priority patent/WO2023198663A1/en
Publication of JP2025512061A publication Critical patent/JP2025512061A/ja
Publication of JP2025512061A5 publication Critical patent/JP2025512061A5/ja
Pending legal-status Critical Current

Links

JP2024560444A 2022-04-12 2023-04-11 Sncaの核酸調節 Pending JP2025512061A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22168001 2022-04-12
EP22168001.0 2022-04-12
PCT/EP2023/059361 WO2023198663A1 (en) 2022-04-12 2023-04-11 Nucleic acid regulation of snca

Publications (2)

Publication Number Publication Date
JP2025512061A JP2025512061A (ja) 2025-04-16
JP2025512061A5 true JP2025512061A5 (cg-RX-API-DMAC7.html) 2026-03-26

Family

ID=81580388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024560444A Pending JP2025512061A (ja) 2022-04-12 2023-04-11 Sncaの核酸調節

Country Status (4)

Country Link
US (1) US20250297252A1 (cg-RX-API-DMAC7.html)
EP (1) EP4508216A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025512061A (cg-RX-API-DMAC7.html)
WO (1) WO2023198663A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025160429A1 (en) * 2024-01-26 2025-07-31 Genzyme Corporation Artificial micrornas targeting snca

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103526A (en) 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
PT3272872T (pt) 2005-10-20 2020-06-26 Uniqure Ip Bv Vetores aav melhorados produzidos em células de insetos
WO2007148971A2 (en) 2006-06-21 2007-12-27 Amsterdam Molecular Therapeutics B.V. Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
HUE029744T2 (en) 2007-07-26 2017-04-28 Uniqure Ip Bv Baculoviral vectors comprising repeated coding sequences with differential codon biases
AU2009215987B2 (en) 2008-02-19 2015-01-22 Uniqure Ip B.V. Optimisation of expression of parvoviral rep and cap proteins in insect cells
WO2011122950A1 (en) 2010-04-01 2011-10-06 Amsterdam Molecular Therapeutics (Amt) Ip B.V. Monomeric duplex aav vectors
WO2012027558A2 (en) * 2010-08-25 2012-03-01 The Trustees Of Columbia University In The City Of New York OPTIMIZED miRNA CONSTRUCTS
JP6198278B2 (ja) 2011-09-08 2017-09-20 ユニキュアー アイピー ビー.ブイ. Aav調製物からの混入ウイルスの除去
WO2015137802A1 (en) 2014-03-10 2015-09-17 Uniqure Ip B.V. Further improved aav vectors produced in insect cells
AU2015370903B2 (en) 2014-12-24 2021-06-17 Uniqure Ip B.V. RNAi induced huntingtin gene suppression
WO2019016349A1 (en) 2017-07-20 2019-01-24 Uniqure Ip B.V. PRODUCTION OF ENHANCED VAA CAPSIDS IN INSECT CELLS
WO2020053258A1 (en) * 2018-09-12 2020-03-19 Uniqure Ip B.V. Rnai induced c9orf72 suppression for the treatment of als/ftd

Similar Documents

Publication Publication Date Title
US20250161485A1 (en) Aav capsid variants and uses thereof
JP2023527354A5 (cg-RX-API-DMAC7.html)
JP2024095717A5 (cg-RX-API-DMAC7.html)
JP7413256B2 (ja) 神経変性疾患の遺伝子治療
JP2021502060A5 (cg-RX-API-DMAC7.html)
WO2023235791A1 (en) Aav capsid variants and uses thereof
JP2020533959A5 (cg-RX-API-DMAC7.html)
US20220380798A1 (en) AAV Expression Cassette and AAV Vectors Comprising the Same
JP2023514242A5 (cg-RX-API-DMAC7.html)
US20250215453A1 (en) Aav capsid variants and uses thereof
JP2013531471A5 (cg-RX-API-DMAC7.html)
JP2024523445A5 (cg-RX-API-DMAC7.html)
JP2023534037A5 (cg-RX-API-DMAC7.html)
JP2023501897A5 (cg-RX-API-DMAC7.html)
JP2025513066A5 (cg-RX-API-DMAC7.html)
JP2023500793A5 (cg-RX-API-DMAC7.html)
JP2024543211A5 (cg-RX-API-DMAC7.html)
US20250388626A1 (en) Aav capsid variants and uses thereof
JP2023553005A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
WO2025038430A1 (en) Aav capsid variants and uses thereof
JP2024542950A5 (cg-RX-API-DMAC7.html)
JP2022522166A5 (cg-RX-API-DMAC7.html)
JP2021534794A5 (cg-RX-API-DMAC7.html)
JP2023551254A5 (cg-RX-API-DMAC7.html)